The lymphocyte-to-monocyte ratio in follicular lymphoma

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors thank the CERCA Programme/Generalitat de Catalunya and the Josep Carreras Foundation for institutional support.

Disclosure statement

MS reports travel expenses and honoraria from Beckman Coulter. JMS has received honoraria from Roche, Gilead, Janssen, Celgene, Servier, Novartis, Mundipharma, Sanofi, Kern‐Pharma, and Takeda, and was a Member of the Board of Directors or advisory committees for Roche, Janssen, Gilead, Celgene, Novartis, Bristol Myers, and Celltrion.